Fingerprint
Dive into the research topics of 'Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial
David W. Dodick, Richard B. Lipton, Stephen Silberstein, Peter J. Goadsby, David Biondi, Joe Hirman, Roger Cady, Jeff Smith
Research output: Contribution to journal › Article › peer-review
107
Scopus
citations